Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Myc proto-oncogene protein | ||
Ligand | BDBM445528 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_2145528 (CHEMBL5029808) | ||
IC50 | 0.600000±n/a nM | ||
Citation | Hill, MD; Quesnelle, C; Tokarski, J; Fang, H; Fanslau, C; Haarhoff, Z; Kramer, M; Madari, S; Wiebesiek, A; Morrison, J; Simmermacher-Mayer, J; Sinz, M; Westhouse, R; Xie, C; Zhao, J; Huang, L; Sheriff, S; Yan, C; Marsilio, F; Everlof, G; Zvyaga, T; Lee, F; Gavai, AV; Degnan, AP Development of BET inhibitors as potential treatments for cancer: A new carboline chemotype. Bioorg Med Chem Lett51:0 (2021) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Myc proto-oncogene protein | |||
Name: | Myc proto-oncogene protein | ||
Synonyms: | BHLHE39 | Class E basic helix-loop-helix protein 39 | MYC | MYC_HUMAN | Proto-oncogene c-Myc | Transcription factor p64 | ||
Type: | PROTEIN | ||
Mol. Mass.: | 48794.95 | ||
Organism: | Homo sapiens (Human) | ||
Description: | ChEMBL_935266 | ||
Residue: | 439 | ||
Sequence: |
| ||
BDBM445528 | |||
n/a | |||
Name | BDBM445528 | ||
Synonyms: | 2-[7-(Dimethyl-1H-1,2,3-triazol-5-yl)-6-fluoro-5-[(S)-oxan-4-yl(phenyl)methyl]-5H-pyrido[3,2-b]indol-3-yl]propan-2-ol | US10683290, Example 20 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H32FN5O2 | ||
Mol. Mass. | 513.6058 | ||
SMILES | Cc1nnn(C)c1-c1ccc2c3ncc(cc3n([C@@H](C3CCOCC3)c3ccccc3)c2c1F)C(C)(C)O |r,wU:18.19,(5.87,4.29,;5.87,2.75,;7.24,2.05,;7,.53,;5.48,.29,;4.71,-1.04,;4.78,1.66,;3.3,2.06,;2.82,3.52,;1.31,3.84,;.28,2.7,;-1.26,2.7,;-2.29,3.84,;-3.79,3.52,;-4.27,2.06,;-3.24,.92,;-1.73,1.24,;-.49,.33,;-.49,-1.21,;.85,-1.98,;2.18,-1.21,;3.51,-1.98,;3.51,-3.52,;2.18,-4.29,;.85,-3.52,;-1.82,-1.98,;-3.15,-1.21,;-4.49,-1.98,;-4.49,-3.52,;-3.15,-4.29,;-1.82,-3.52,;.76,1.24,;2.27,.92,;2.74,-.55,;-5.76,1.66,;-6.85,2.75,;-6.16,.17,;-7.24,1.26,)| | ||
Structure |